Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression

Affiliations

Yongyong Yang: Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
Annalisa Di Ruscio: Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA, United States
Annalisa Di Ruscio: Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States
Satoshi Inoue: Department of Systems Aging Science and Medicine, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Satoshi Inoue: Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan
Guocan Wang: Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Shuai Gao: Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, United States
Shuai Gao: Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, United States

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/